Written by: Israel Investor Newsletter | June 28, 2007
Douglas Goldstein, CFP
www.IsraelNewsletter.com
“Event driven” analysts look for some extraordinary change in a market or a company and try to make a quick play. Some of the smaller Israeli stocks that we follow move on events, too; but what’s interesting is that given their small daily volume and almost micro-market cap, seemingly minor press releases can push a stock’s price tag. Just today, for example, when ClickSoftware (CKSW), a small-scale competitor of Oracle (ORCL), announced that their CFO would be presenting at the C.E. Unterberg Emerging Growth Opportunities Conference in New York next month, the stock jumped 3%. A month ago, when they announced that one of Canada’s largest natural gas distributors had successfully gone live with their ClickLocate solution, their stock also popped. Subsequently, the stock settled back down.
For traders, keeping an eye on the small Israeli stocks for a quick move, either going long in anticipation of a news story that need not even be too dramatic, or going short just as the news comes out, there are opportunities for profit. Take a look at IsraelNewsletter’s list of Israeli stocks that trade in the U.S. to get some ideas.
*****
Disclosure: Author’s fund is does not own any of the companies mentioned herein as of 6/2807.
Please see our Disclaimer HERE.
Douglas Goldstein is the Managing Director of America Israel Investment Associates, LLC. For more information, go to www.israelnewsletter.com or call 1-888-327-6179, or email doug@profile-financial.com.
Written by: Aaron Katsman | June 27, 2007
By Aaron Katsman
www.IsraelNewsletter.com
It’s been quite a week for Given Imaging (GIVN) shareholders. The week started off with the BooYa man himself Jim Cramer recommending the stock, and then today’s news that the Japanese central health insurance committee will reimburse patients who use the PillCam for diagnosis of abdominal symptoms. This is a huge win for the company as Japan is, by most accounts, the second biggest healthcare market in the world.
This win proves what I posted on the company a month ago, that Given Imaging has successfully begun to execute their business plan. Since that posting on the 15th of May, the stock has risen more than 15%, and like Cramer, I believe that this is one of the most exciting long-term Israeli plays out there. Keep in mind potential short-term volatility in the stock caused by profit takers as well as the fact that the local Tel Aviv stock exchange has a habit of poorly performing during July. With that in mind, any weakness should be used as a buying opportunity.
Disclosure: Author’s fund is long GIVN as of 6/27/07.
Please see our Disclaimer HERE.
Like what you see? Sign up to receive daily updates from IsraelNewsletter here
Aaron Katsman is the lead portfolio manager for the Israel Growth Portfolio and Managing Director of America Israel Investment Associates, LLC. For more information, go to www.israelnewsletter.com or call 1-888-327-6179, or email aaron@profile-financial.com.
Written by: Aaron Katsman | June 26, 2007
By Aaron Katsman
www.IsraelNewsletter.com
With today’s news that Marvell Technology has received a stay from the Nasdaq’s board, and will retain its listing at least until the July hearing, and the settlements that we have started seeing in the option backdating scandal, the question on many Israeli investors’ minds is when will we get some information on Comverse (CMVT.pk). I want to be clear that I don’t think anyone really knows, but many local fund managers and people close to the company believe a resolution is imminent, and that could very well lead to a potential relisting on the Nasdaq.
As I have mentioned recently, I think this will spell reward for investors as we will start to unlock the full value of the company.
The stock has fallen hard, about 15% over the last few weeks, but as the stock has neared $20, we have seen a nice bounce, as intelligent investors sense a good deal is on the horizon.
Like what you see? Sign up to receive daily updates from IsraelNewsletter here.
Please see our Disclaimer HERE.
Disclosure: Author’s fund is long CMVT.pk and MRVL as of 6/26/07. He does not hold positions in the other companies listed.
Aaron Katsman is the lead portfolio manager for the Israel Growth Portfolio and Managing Director of America Israel Investment Associates, LLC. For more information, go to www.israelnewsletter.com or call 1-888-327-6179, or email aaron@profile-financial.com.
Written by: Zack Miller | June 26, 2007
Kudos to Israel Newsletter’s Aaron Katsman who appeared in a lead article on Verint (VRNT.PK) on TheStreet.com yesterday. Two years ago, when Katsman added it to his portfolio, he thought “it was a strong growth company in what was perceived as an up-and-coming niche.”
LivePerson (LPSN) buying Israeli social networking and Web 2.0 firm, Kasamba, in a combined cash/stock deal valued at $40MM. See the Globes story. LivePerson said that the acquisition of Kasamba, combined with the recently announced launch of LivePersonalShoppers.com, will accelerate its expansion into the direct-to-consumer market.
Robert De Niro and Africa-Israel Investments’ (AFIVY.PK) Lev Leviev in talks to develop a luxury hotel in New York City’s Clock Tower. Africa-Israel closed its $200MM purchase of the historic hotel last Wednesday.
Sky Israel Private equity fund, run by Zvi Yochman and Nir Dagan, is selling their 11.6% stake in Internet Service Provider, Netvision. IDB Holding, Netvision’s controlling shareholder, is buying the stake and will own 35% of Netvision after the sale.
Page 1 of 1112345»...Last »
